Latest news

CHK1 Research Update

First description of the CHK1 clinical development candidate published in peer-reviewed journal: New ‘chemotherapy booster’…

23 July 2015

FUNDING AWARD FROM INNOVATE UK

Award of up to £140,000 to investigate the potential of TYK2 inhibitors to treat adolescent leukaemia

17 June 2015

Placing

28 May 2015

Find out more

Partners

Sareum actively seeks collaboration partners for its research programmes.

Find out more large-arrow.png

Pipeline

Sareum has an innovative pipeline of drug development candidates.

Find out more large-arrow.png